Marriott Vacations Worldwide enters the post-earnings period in a paradox: it missed Q1 estimates by $0.43 per share, yet the stock is up 9% over the past month and shorts have been cutting positions at one of the steepest rates on the market.
The short covering is the most striking data point right now. Short interest has fallen nearly 37% over the past 30 days — from roughly 3.3 million shares short in late March to just 2.08 million now, equivalent to about 6% of the free float. The pace of that decline is not a small adjustment. It represents a meaningful unwind of a bearish thesis that had been building through the first quarter. Availability in the lending market has loosened as the short base contracted, and borrow remains exceptionally cheap at 0.43% annualised — borrowing conditions for new shorts are easy, but fewer investors appear interested. The ORTEX short score has drifted back toward neutral at 50.7, down from readings above 52 at the end of April, reflecting that both sides of the borrow market have calmed.
Options positioning has swung notably more bullish alongside the price recovery. The put/call ratio has dropped to 0.97, well below its 20-day average of 1.11. Through most of April, the PCR was running comfortably above 1.3 — consistent with investors hedging against downside — but that defensive posture has largely unwound in the past two sessions following the earnings release. The 52-week range for the PCR runs from 0.24 to 1.53, so the current reading is neither extreme; it simply reflects a rapid mood shift from caution to something closer to neutral-to-mildly-constructive.
The Street's reaction to Q1 was measured but directionally positive. Barclays, reacting directly to the earnings print on May 6, raised its target from $80 to $94 while maintaining its Overweight rating — the most prominent move this week. That puts Barclays toward the bullish end of the current range. Morgan Stanley stays at Underweight with a $50 target, and Wells Fargo also holds Underweight despite nudging its target to $58 — together those two create a clear bear bloc. The mean Street target is $81.90, implying about 11% upside from Tuesday's close of $73.72. The bull case centres on recovering development margins and timeshare demand resilience; the bear case focuses on declines in exchange revenues, contract sales, and active member counts. Valuation sits at roughly 9.4x trailing earnings and 10.2x EV/EBITDA — both multiples have drifted higher over the past 30 days as the stock recovered, which slightly compresses the margin of safety for new buyers. Earlier in the week, Zacks moved VAC to Strong Buy, adding another voice to the constructive camp.
The institutional picture adds a layer of confidence to the recovery narrative. BlackRock added 650,000 shares in Q1 2026 to hold 12.2% of the company — by far the largest institutional position. Citadel and AQR both built meaningful new positions in Q4 2025, and the insider activity from March is worth noting: President and COO Michael Flaskey bought nearly $1 million worth of shares across multiple transactions on March 10, with the stock trading near $67. That purchase now sits comfortably in the money. The factor scores are mixed but not alarming — EPS momentum over 90 days ranks in the 84th percentile, but the 30-day figure is weaker at the 33rd, consistent with a name where near-term estimate pressure persists even as the longer trajectory improves.
The next confirmed earnings event is May 15. The more important question heading into that date is whether the Q1 miss was a guidance reset or a sign of structural pressure in contract sales — and whether the operating margin improvement story Barclays is pricing in at $94 can survive the bear camp's argument that membership attrition and per-member revenue declines represent a more durable headwind than a single quarter's cost improvement.
See the live data behind this article on ORTEX.
Open VAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
